> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Public Citizen Calls for Shuren Probe by OIG
- URL: https://www.fdaweb.com/public-citizen-calls-for-shuren-probe-by-oig/
- Published: 2024-08-23T12:00:00.000Z
- Updated: 2026-09-14T14:39:28.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5157641

Public Citizen’s Health Research Group is calling on HHS’ Office of Inspector General to launch an investigation into allegations that retiring CDRH director **Jeff Shuren** failed to recuse himself from potential conflict-of-interest matters involving medical device firms being represented by his wife’s law firm. An 8/20 *New York Times* investigative article exposed the alleged conflicts of interest in Shuren’s regulatory role and the legal work done by his wife **Allison** for the same industry at the iconic industry law firm of Arnold & Porter ([see earlier story](https://www.fdaweb.com/expose-hits-ethics-conflicts-in-shurens-job-and-wifes-industry-roles/)).

“Dr. Shuren signed ethics agreements obtained by the *Times* that were meant to wall him off from matters involving Arnold & Porter’s business,” the [article](https://www.nytimes.com/2024/08/20/health/fda-medical-devices-ethics.html?ref=fdaweb.com) said. “But it’s not clear how rigorously the ethics agreements were actually enforced… In a review of thousands of pages of court documents and FDA records and dozens of interviews with current and former agency staff members and advocates, the *Times* identified some clients and several instances in which the Shurens’ roles intersected.”

Public Citizen Health Research Group director **Robert Steinbrook** is quoted in a [release](https://www.citizen.org/news/office-of-inspector-general-at-department-of-health-and-human-services-should-investigate-conflict-of-interest-allegations-against-senior-fda-official/?ref=fdaweb.com) as calling the revelations very troubling. “There are long-standing concerns that the FDA’s regulation of medical devices has been too friendly to industry under Shuren’s leadership and has not prioritized patient safety and the effectiveness of novel medical devices," it says. "The Office of Inspector General at DHHS should formally investigate the allegations in the *New York Times* article. And the FDA must appoint a new director of the Center for Devices and Radiological Health who has no conflicts of interest and prioritizes patients’ interests.”